Tudor Investment Corp’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Tudor Investment Corp's IRMD Position: Q2 2026 in Review
Tudor Investment Corp reduced its iRadimed (IRMD) stake by 36% in Q2 2026, selling an estimated $2.39M and leaving 45,626 shares worth $4.36M. The position accounts for 0.01% of the portfolio, ranked #1382.
Tudor Investment Corp first reported a position in IRMD in Q1 2023 and has held it in 12 quarters since. The position peaked at $6.91M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Tudor Investment Corp held 45,626 shares of iRadimed worth $4.36M as of Q2 2026.
- Tudor Investment Corp sold 26,210 iRadimed shares in Q2 2026, an estimated $2.39M.
- iRadimed made up 0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #1382 holding.
- Tudor Investment Corp first reported a position in iRadimed in Q1 2023 and has held it in 12 quarters since.
- Tudor Investment Corp's iRadimed position peaked at $6.91M in Q1 2026.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.